Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Blog
Supplements
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Blog
Supplements
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Table of contents
Table of contents
Email alerts
Table of contents
Prev issue
Next issue
May 2021 - Volume 6 - Suppl 3
Social and ethical issues of poor quality and poor use of medical products
Editorial
Uncertainties about the quality of medical products globally: lessons from multidisciplinary research
(21 June, 2023)
Patricia
Kingori
,
Koen
Peeters Grietens
,
Seye
Abimbola
,
Raffaella
Ravinetto
Analysis
Insights from a qualitative study of the procurement and manufacture of active pharmaceutical ingredients in India
(17 May, 2023)
Heather
Hamill
,
Kate
Hampshire
,
Harshada
Vinaya
,
Pavan
Mamidi
Commentary
How the concept of WHO-listed authorities will change international procurement policies for medicines
(10 February, 2022)
Cécile
Macé
,
Lembit
Rägo
,
Raffaella
Ravinetto
Practice
Elusive quality: the challenges and ethical dilemmas faced by international non-governmental organisations in sourcing quality assured medical products
(28 May, 2021)
Katherine
Enright
Original research
Antimalarial stocking decisions among medicine retailers in Ghana: implications for quality management and control of malaria
(21 September, 2023)
Adams
Osman
,
Fiifi
Amoako Johnson
,
Simon
Mariwah
,
Daniel
Amoako-Sakyi
,
Samuel
Asiedu Owusu
,
Martins
Ekor
,
Heather
Hamill
,
Kate
Hampshire
Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania
(10 September, 2023)
Gerry
Mshana
,
Tubeti
Mayebe
,
Rebecca
Balira
,
Heather
Hamill
,
Kate
Hampshire
Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
(2 February, 2023)
Zuzana
Kusynová
,
Youssra
Bais
,
Hendrika A
van den Ham
,
Aukje K
Mantel-Teeuwisse
,
Gisele
Etame-Loe
,
Eliangiringa
Kaale
,
Serigne Omar
Sarr
,
Fatima
Guiet-Mati
,
Pernette
Bourdillon-Esteve
Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan
(2 February, 2023)
Muhammad Naveed
Noor
,
Afifah
Rahman-Shepherd
,
Amna Rehana
Siddiqui
,
Wafa
Aftab
,
Sadia
Shakoor
,
Rumina
Hasan
,
Mishal
Khan
Why falsified medicines reach patients: an analysis of political and economic factors in Romania
(2 February, 2023)
Adina-Loredana
Nistor
,
Elizabeth
Pisani
,
Maarten Olivier
Kok
Implementing pharmaceutical track-and-trace systems: a realist review
(28 May, 2021)
Joeke
Kootstra
,
Tineke
Kleinhout-Vliek
Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania
(28 May, 2021)
Heather
Hamill
,
Elizabeth
David-Barrett
,
Joseph Rogathe
Mwanga
,
Gerry
Mshana
,
Kate
Hampshire
Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia
(28 May, 2021)
Amalia
Hasnida
,
Maarten Olivier
Kok
,
Elizabeth
Pisani
Commentary